Martijn Kleijwegt - Net Worth and Insider Trading

Martijn Kleijwegt Net Worth

The estimated net worth of Martijn Kleijwegt is at least $7 dollars as of 2024-11-13. Martijn Kleijwegt is the Director of Eloxx Pharmaceuticals Inc and owns about 73,842 shares of Eloxx Pharmaceuticals Inc (ELOX) stock worth over $7. Details can be seen in Martijn Kleijwegt's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Martijn Kleijwegt has not made any transactions after 2018-04-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Martijn Kleijwegt

To

Martijn Kleijwegt Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Martijn Kleijwegt owns 3 companies in total, including Eloxx Pharmaceuticals Inc (ELOX) , European Biotech Acquisition Corp (EBACU) , and European Biotech Acquisition Corp (EBAC) .

Click here to see the complete history of Martijn Kleijwegt’s form 4 insider trades.

Insider Ownership Summary of Martijn Kleijwegt

Ticker Comapny Transaction Date Type of Owner
ELOX Eloxx Pharmaceuticals Inc 2018-04-30 director
EBACU European Biotech Acquisition Corp 2021-03-15 director
EBAC European Biotech Acquisition Corp 2021-03-15 director

Martijn Kleijwegt Latest Holdings Summary

Martijn Kleijwegt currently owns a total of 1 stock. Martijn Kleijwegt owns 73,842 shares of Eloxx Pharmaceuticals Inc (ELOX) as of April 30, 2018, with a value of $7.

Latest Holdings of Martijn Kleijwegt

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ELOX Eloxx Pharmaceuticals Inc 2018-04-30 73,842 0.00 7

Holding Weightings of Martijn Kleijwegt


Martijn Kleijwegt Form 4 Trading Tracker

According to the SEC Form 4 filings, Martijn Kleijwegt has made a total of 0 transactions in Eloxx Pharmaceuticals Inc (ELOX) over the past 5 years. The most-recent trade in Eloxx Pharmaceuticals Inc is the acquisition of 7,500 shares on April 30, 2018, which cost Martijn Kleijwegt around $3 Million.

Insider Trading History of Martijn Kleijwegt

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Martijn Kleijwegt Trading Performance

GuruFocus tracks the stock performance after each of Martijn Kleijwegt's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Martijn Kleijwegt is 23.39%. GuruFocus also compares Martijn Kleijwegt's trading performance to market benchmark return within the same time period. The performance of stocks bought by Martijn Kleijwegt within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Martijn Kleijwegt's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Martijn Kleijwegt

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 15 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 12.13 LIMIT LIMIT LIMIT LIMIT LIMIT

Martijn Kleijwegt Ownership Network

Ownership Network List of Martijn Kleijwegt

No Data

Ownership Network Relation of Martijn Kleijwegt

Insider Network Chart

Martijn Kleijwegt Owned Company Details

What does Eloxx Pharmaceuticals Inc do?

Who are the key executives at Eloxx Pharmaceuticals Inc?

Martijn Kleijwegt is the director of Eloxx Pharmaceuticals Inc. Other key executives at Eloxx Pharmaceuticals Inc include HEAD OF R&D Vijay Modur , director & PRESIDENT AND CEO Sumit Aggarwal , and Chief Financial Officer Daniel E. Geffken .

Eloxx Pharmaceuticals Inc (ELOX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Eloxx Pharmaceuticals Inc (ELOX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Eloxx Pharmaceuticals Inc (ELOX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Eloxx Pharmaceuticals Inc (ELOX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Eloxx Pharmaceuticals Inc Insider Transactions

No Available Data

Martijn Kleijwegt Mailing Address

Above is the net worth, insider trading, and ownership report for Martijn Kleijwegt. You might contact Martijn Kleijwegt via mailing address: Johannes Vermeerplein 9, Amsterdam P7 1071 Dv.